EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy

Melissa Chan, Joshua Yoon, Jennifer J Telford, Chipman T Drury, Tony Wan

TH Open · 01.04.2024 · 08 (02) · e216-e223

DOI: 10.1055/s-0044-1787553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift TH Open, erschienen am 01.04.2024. Verfasst von Melissa Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Columbia, Vancouver, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Objective Colonoscopy with polypectomy is an integral component of colorectal cancer screening. There are limited data and consensus on periprocedural anticoagulation management, especially regarding bleeding risk with uninterrupted anticoagulation and thromboembolic risk with interruption. Our aim was to determine the incidence of bleeding and thromboembolic complications among colon screening participants undergoing colonoscopy following implementation of a novel patient care pathway for standardized periprocedural anticoagulation management.

Methods

We conducted a retrospective study including all participants (age 50–74) on an oral anticoagulant (e.g., vitamin K antagonists, direct oral anticoagulants) referred to the British Columbia Colon Screening Program for colonoscopy following abnormal fecal immunochemical test in a 6-month period (March–August 2022). Data relating to their specific periprocedural anticoagulant management and colonoscopy results including method of polypectomy were obtained. Primary outcomes were major bleeding and arterial or venous thromboembolic events from time of oral anticoagulant interruption until 14 days of postcolonoscopy. Secondary outcomes included nonmajor and minor bleeding, acute coronary syndrome, emergency room visit, hospital admission, and death due to any cause.

Results

Over the 6-month period, 162 participants completed standardized periprocedural anticoagulation management, colonoscopy ± polypectomy, and 14-day follow-up. One (0.6%) had a major bleeding event and one (0.6%) had an arterial thromboembolic event.

Conclusions

A novel patient care pathway for standardized periprocedural anticoagulation management with a multidisciplinary team is associated with low rates of major bleeding and thrombotic complications after colonoscopy with polypectomy.

Schlagwörter

Stichwörter der Autor:innen

anticoagulationcolonoscopyperiprocedural managementpolypectomy

Autor:innen und Institutionen

  • Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Division of Gastroenterology, University of British Columbia, Vancouver, Canada.
  • British Columbia Colon Screening Program, BC Cancer, Vancouver, Canada.
  • Division of General Internal Medicine, University of British Columbia, Vancouver, Canada.

Zitieren

APA

Chan, M., Yoon, J., Telford, J. J., Drury, C. T., & Wan, T. (2024). Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy. TH Open, 08(02), e216-e223. https://doi.org/10.1055/s-0044-1787553

Vancouver

Chan M, Yoon J, Telford JJ, Drury CT, Wan T. Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy. TH Open. 2024;08(02):e216-e223. doi:10.1055/s-0044-1787553

BibTeX
@article{Chan2024,
  author = {Chan, Melissa and Yoon, Joshua and Telford, Jennifer J and Drury, Chipman T and Wan, Tony},
  title = {Periprocedural Anticoagulation Management of Patients Undergoing Colonoscopy with Polypectomy},
  journal = {TH Open},
  year = {2024},
  volume = {08},
  number = {02},
  pages = {e216--e223},
  doi = {10.1055/s-0044-1787553}
}
Kostenlos starten →